By Scott Gottlieb (Original source The Cut)
Well, shoot.
“The FDA commissioner Scott Gottlieb announced his unexpected resignation on Tuesday, in a letter the FDA tweeted. The reasons are unclear, but it leaves a lot of people extremely disappointed, myself among them. (He’s been commuting to D.C. from Connecticut and says he misses his wife and young family.)
Since his appointment in May of 2017, Gottlieb has earned wide bipartisan support as a public-health advocate (also unexpected, given his previous ties to the pharmaceutical industry), due in large part to his efforts to curb the opioid epidemic, which he told CNN last year was the “biggest crisis” facing the FDA. “Gottlieb has been shockingly good so far,” Stanford public policy expert Keith Humphreys told Vox. (However, Harvard professor and FDA-scrutinizer Daniel Carpenter said the “jury is still out” on Gottlieb’s legacy, in an interview with STAT.)”
Click here to see more
Marc Short On The Possibility of the GOP Raising Taxes on Upper-Income Brackets
Former White House Director of Legislative Affairs Marc Short joined MSNBC to share his insights on the Republican Party’s evolving stance on tax policy. He…
Thought Leader: Marc Short
Ryan Dusick: Our Young Men Are Struggling – A Look Into “Adolescence” on Netflix
In today’s episode of Harder to Breathe, host Ryan Dusick, founding drummer of Maroon 5 and licensed therapist, teams up with actor Brian “Duck” Maillard…
Thought Leader: Ryan Dusick
Dr. Sanjay Gupta: Go Outside, Doctor’s Orders
How does our relationship with nature affect our health, for better and worse? Dr. Sanjay Gupta explores this idea by pulling from personal experience as…
Thought Leader: Sanjay Gupta
Dr. Scott Gottlieb: Navigating Pharma Tariffs
Thought Leader: Scott Gottlieb
